Utah-based interventional medical devices company Scientia Vascular has received $50m of growth equity financing from global healthcare investment firm Vivo Capital. The company intends to use...
binx health, a Boston, MA-based healthcare technology and diagnostics company, closed a Series E financing of $104m. The round was led by OrbiMed, with participation from...
Varian announced today that it received FDA breakthrough device designation for its cardiac radioablation (CRA) system. Palo Alto, Calif.-based Varian, a recently acquired Siemens Healthineers company,...
Boston Scientific Corporation has received a CE Mark for the EXALT Model B Single-Use Bronchoscope, a single-use device designed for bedside procedures in the intensive care...
QIAGEN N.V. today announced the launch of an expanded scope of companion diagnostic claims for the therascreen® KRAS RGQ PCR Kit after it received U.S. regulatory...
Medtronic announced today that it received CE mark approvals for its InPen smart insulin pen and its Guardian 4 sensor. Fridley, Minn.-based Medtronic’s new European approvals...
Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced FDA approval for the company to initiate...
Shares of Medtronic PLC MDT, -0.89% slipped 0.1% in premarket trading Thursday, after the medical technology and services company reported fiscal fourth-quarter profit and sales that...
Diversified conglomerate Hinduja Group’s plans to unlock value in its BPO arm Hinduja Global Solutions with the sale of a carved out business vertical have reached...
Zydus Cadila and Taiwan-based specialty pharmaceutical firm TLC on Wednesday said they have signed a pact to market Liposomal Amphotericin B, a critical drug to treat...
Zydus has announced biological therapy ZRC-3308, used to treat mild COVID-19. The pharmaceutical company now seeks DCGI (Drugs Controller General of India) nod to undertake clinical...
Vectura Group, a British pharmaceutical company focused on inhaled medicines, said on Wednesday it had agreed a 958 million pound ($1.36 billion) takeover by global investment...
CollPlant , a regenerative and aesthetic medicine company, today announced financial results for the first quarter ended March 31, 2021 and provided an update on the...
GenapSys, Inc. a company developing a highly accurate and scalable electronic sequencing platform, today announced it has raised $70 million in a Series D equity financing....
Micro Interventional Devices (has received Breakthrough Device Designation from the U.S. Food and Drug Administration for its MIA™-T Percutaneous Tricuspid Annuloplasty System. The MIA-T system treats...
Copyright © 2024 Medical Buyer